ストックスクリーナーアプリを入手
1.02
3.77%
-0.04
アフターアワーズ：
1.02
前日終値:
$1.06
開ける：
$1.08
24時間の取引高:
180.58K
Relative Volume:
1.18
時価総額：
$25.81M
収益：
-
当期純損益:
$-3,000
株価収益率:
0.2023
EPS:
5.0425
ネットキャッシュフロー:
$-13.22M
1週間 パフォーマンス:
-10.53%
1か月 パフォーマンス:
-11.30%
6か月 パフォーマンス:
+30.99%
1年 パフォーマンス:
+51.99%
1日の値動き範囲:
$0.98
$1.08
1週間の範囲:
$0.98
$1.24
52週間の値動き範囲:
$0.375
$1.45
AEON Biopharma Inc. Stock (AEON) Company Profile
Compare AEON vs VRTX, REGN, ALNY, ARGX, INSM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AEON
AEON Biopharma Inc.
|
1.02 | 26.82M | 0 | -3,000 | -13.22M | 5.0425 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-08-18 | 開始されました | H.C. Wainwright | Buy |
AEON Biopharma Inc. (AEON) 最新ニュース
AEON Biopharma receives FDA feedback on botulinum toxin biosimilar - Investing.com
AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program - The Manila Times
FDA maps next steps for AEON's bid to bring a Botox biosimilar - Stock Titan
AEON Biopharma (AEON) Projected to Post Quarterly Earnings on Wednesday - Defense World
If You Invested $1,000 in Aeon Biopharma (AEON) - Stock Titan
Technical Analysis: Whats the profit margin of AEON Biopharma Inc2026 WrapUp & Weekly Market Pulse Updates - baoquankhu1.vn
Travel Stocks: How much upside does AEON Biopharma Inc haveQuarterly Trade Summary & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Profit Recap: Can AEON Biopharma Inc stock outperform in a bear marketMarket Performance Report & Low Risk Entry Point Guides - baoquankhu1.vn
Risk Analysis: Is AEON Biopharma Inc stock good for income investors2026 Trade Ideas & Safe Entry Point Identification - baoquankhu1.vn
AEON Technical Analysis | Trend, Signals & Chart Patterns | AEON BIOPHARMA INC (NYSEARCA:AEON) - ChartMill
AEON Biopharma (NASDAQ: AEON) CMO granted RSUs and modifies 1,316,872-unit award - Stock Titan
AEON Biopharma names John Bencich as chief financial officer - Investing.com Australia
AEON Biopharma Appoints John Bencich as Chief Financial Officer - The Manila Times
AEON Biopharma Strengthens Finance Leadership with New CFO - TipRanks
AEON Biopharma names John Bencich as chief financial officer By Investing.com - Investing.com Canada
AEON appoints John Bencich as CFO; Jennifer Sy employment terms confirmed - TradingView
New AEON Biopharma (NYSE: AEON) CFO hired as company expands inducement equity pool - Stock Titan
AEON Biopharma, Inc. Appoints John Bencich as Chief Financial Officer, Effective as of March 9, 2026 - marketscreener.com
How cyclical is AEON Biopharma Inc. Class stock compared to rivalsInflation Watch & AI Enhanced Trading Signals - Naître et grandir
AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting - The Manila Times
AEON (AEON) CLO adds large stock awards and converts prior RSUs - Stock Titan
AEON Biopharma (AEON) details major stock unit grants to officer - Stock Titan
Botox biosimilar study from AEON Biopharma set for big U.S. neurology meeting - Stock Titan
AEON PE Ratio & Valuation, Is AEON Overvalued - Intellectia AI
Breakout Zone: Is AEON Biopharma Inc stock good for income investorsJuly 2025 Action & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
AEON Technical Analysis & ETF Price Forecast - Intellectia AI
Will AEON Biopharma Inc. outperform small cap indexes2025 Sector Review & Real-Time Volume Triggers - mfd.ru
AEON Biopharma (AEON) CEO awarded 3,000,000 restricted stock units - Stock Titan
AEON (AEON) files resale prospectus for up to 51.3M shares - Stock Titan
Guidance Update: Whats the profit margin of AEON Biopharma IncWeekly Market Outlook & AI Driven Price Forecasts - baoquankhu1.vn
Will AEON Biopharma Inc. stock benefit from commodity pricesJuly 2025 Sentiment & Technical Buy Zone Confirmation - mfd.ru
Short Covering: Can AEON Biopharma Inc. weather a recessionWeekly Trading Summary & Weekly Watchlist of Top Performers - baoquankhu1.vn
Profit Review: Is AEON Biopharma Inc in a long term uptrendMarket Sentiment Summary & Daily Stock Trend Reports - baoquankhu1.vn
Midday Stock Roundup: MDxHealth Up 9% Since Preliminary Q4, FY Results - Orange County Business Journal
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions - The Manila Times
AEON Biopharma completes FDA meeting, shareholders approve transactions - Investing.com
Aeon Biopharma stock falls after FDA meeting and debt restructuring By Investing.com - Investing.com Nigeria
Aeon Biopharma stock falls after FDA meeting and debt restructuring - Investing.com
Aeon Biopharma Reports bpd Type 2A Meeting With FDA And Shareholder Approval Of The November Transactions - TradingView
AEON Biopharma completes FDA meeting, shareholders approve transactions By Investing.com - Investing.com Nigeria
Shareholders back AEON debt-cut deals after FDA meeting on Botox biosimilar - Stock Titan
Growth Value: Is AEON Biopharma Inc stock good for income investorsQuarterly Trade Summary & Community Supported Trade Ideas - baoquankhu1.vn
Is EverQuote Inc. stock attractive for passive investorsWeekly Investment Summary & Long-Term Safe Return Strategies - bollywoodhelpline.com
Midday Stock Roundup: loanDepot Jumps on Trump’s Proposed Mortgage Plan - Orange County Business Journal
Rate Cut: Whats the MACD signal for AEON Biopharma Inc2025 Macro Impact & AI Powered Market Entry Ideas - baoquankhu1.vn
Do Not Use - ocbj.com
Market Wrap: Can AEON Biopharma Inc keep up with sector leadersJuly 2025 Rallies & Risk Controlled Swing Alerts - baoquankhu1.vn
AEON Biopharma (AEON) Price Target Decreased by 14.75% to 5.30 - Nasdaq
Midday Stock Roundup: Staar Down 4% on Board Changes - Orange County Business Journal
AEON Biopharma Releases Updated Investor Presentation Under Reg FD - TipRanks
AEON Biopharma Inc. (AEON) 財務データ
収益
当期純利益
現金流量
EPS
1.82%
大文字化:
|
ボリューム (24 時間):